India, July 21 -- Globus Medical, Inc. (GMED), Monday announced the resignation of Daniel Scavilla from the role of President and Chief Executive Officer effective July 18, 2025, to pursue another opportunity.
Following this, the company has appointed Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, as CEO.
Concurrently, the company announced preliminary results for the second quarter ending June 30, 2025, expecting sales of approximately $745.3 million, an as-reported increase of 18.4 percent over the second quarter of 2024.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Moreover, the company reaffirmed its full-year 2025 revenue guidance to be in the rang...